Innovation

Elixir has been founded in 2014 as a pharmaceutical research and development company, aiming to serve global pharmaceutical industry through its high technology laboratories, scientific background and innovative thinking.

Pharmaceutical Development

Elixir develops drug products and manufacturing processes meeting EMA and FDA standards, performs technology transfer to pharmaceutical manufacturing sites, and conducts co-development studies with clients and strategic partners operating in Turkey, EU and the US.

Expertise

We focus on the development of oral solid, oral liquid, semi-solid, nasal and parenteral dosage forms among others, and specialise in integrating Quality by Design (QbD) and Process Analytical Technology (PAT) into pharmaceutical development studies.